Close

Canaccord Genuity Reiterates a 'Hold' on Protalix BioTherapeutics (PLX); Modest U.S. But Strong In Israel

Go back to Canaccord Genuity Reiterates a 'Hold' on Protalix BioTherapeutics (PLX); Modest U.S. But Strong In Israel